Abstract Body

Background: Following launch of the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive in June 2011 and the April 2012 WHO programmatic update that offered Option B+ for PMTCT several countries including Uganda adopted the provision of triple ARVs to HIV positive pregnant and lactating women for life regardless of CD4 count. Option B+ covers the estimated 40-60% of HIV positive pregnant women accessing PMTCT who need treatment for their own health and account for nearly 90% of all vertical HIV infections but also contribute to sexual transmission. However the adoption of option B+ requires changes in national policies and guidelines more effective integration of ART into MNCH while at the same time eliminating critical losses along the PMTCT cascade in order to ensure universal coverage and retention of mother-baby pairs. While option B+ is likely to have more impact on elimination of HIV in the high HIV burden countries the implementation of this strategy also presents health system challenges. Continuous review of these large scale HIV test and treat interventions will provide valuable lessons to improve the effectiveness of Option B+ programs. Conclusions: For optimal reduction of MTCT population coverage for maternal and infant ARV uptake needs to be improved. Monitoring tools need to be revised to ease completion and improve quality of data. Evaluation and adoption of service delivery models that foster optimal retention and adherence for mother-baby pairs initiating ART through PMTCT will maximize the impact of Option B+ towards EMTCT.